Project 1-lntraperitoneal PDT PI: Douglas Fraker Peritoneal carcinomatosis is a clinical problem which causes considerable morbidity and is uniformly fatal. Complete surgical resection is not possible, conventional radiation therapy is unable to safely treat all areas at risk, and systemic therapy with available agents is limited by drug delivery and efficacy. Intraperitoneal spread represents cancer progression on a complex surface and all areas of the abdominal cavity are at risk. During the first grant funding cycle we have demonstrated that surgical tumor debulking to minimal disease and intra-operative photodynamic therapy can be performed to treat all surfaces at risk. There were clinical responses seen in this heavily pre-treated population but the majority of patients recurred within the peritoneal cavity. This initial Phase II trial using photofrin was limited primarily by low photosensitizer retention in tumor compared to normal tissues. Other potential problems include the difficulty in delivering uniform light dose to a complex surface, and tumor hypoxia which may decrease PDT cytotoxicity. In the current proposal, Project I will address these problems by utilizing a second generation photosensitizer in combination with targeting agents to alter the signal transduction cascade in tumors. We propose to evaluate the second generation photosensitizer, benzoporphyrin derivative (BPD) in combination with the EGFR inhibitor, C225 based upon preliminary data suggesting this will increase the therapeutic index of IP PDT. Initial preclinical studies will be conducted in rabbits including peritoneal PDT at increasing doses of photosensitizer with and without bowel anastomoses. A Phase l/ll clinical trial will be performed on patients with peritoneal carcinomatosis from ovarian or gastro-intestinal cancers who have no other treatment options. The initial phase of the trial will identify and optimal dose of BPD and light energy. A second phase of the protocol will add C225 to assess response rates. In all parts of the trial malignant and normal tissue will be analyzed for sensitizer concentration, molecular markers related to PDT response, and intraoperatively for optical properties.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Davis 4th, Richard W; Snyder, Emma; Miller, Joann et al. (2018) Luminol Chemiluminescence Reports Photodynamic Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic Efficacy. Photochem Photobiol :
Cramer, Gwendolyn; Simone 2nd, Charles B; Busch, Theresa M et al. (2018) Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma. J Thorac Dis 10:S2565-S2573
Ong, Yi Hong; Padawer-Curry, Jonah; Finlay, Jarod C et al. (2018) Determination of optical properties, drug concentration, and tissue oxygenation in human pleural tissue before and after Photofrin-mediated photodynamic therapy. Proc SPIE Int Soc Opt Eng 10476:
Ong, Yi Hong; Kim, Michele M; Huang, Zheng et al. (2018) Reactive Oxygen Species Explicit Dosimetry (ROSED) of a Type 1 Photosensitizer. Proc SPIE Int Soc Opt Eng 10476:
Zhu, Timothy C; Kim, Michele M; Padawer, Jonah et al. (2018) Light Fluence Dosimetry in Lung-simulating Cavities. Proc SPIE Int Soc Opt Eng 10476:
Chandra, Abhishek; Wang, Luqiang; Young, Tiffany et al. (2018) Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis. FASEB J 32:52-62
Ong, Yi Hong; Finlay, Jarod C; Zhu, Timothy C (2018) Monte Carlo modelling of fluorescence in semi-infinite turbid media. Proc SPIE Int Soc Opt Eng 10492:
Yan, Lesan; Amirshaghaghi, Ahmad; Huang, Dennis et al. (2018) Protoporphyrin IX (PpIX)-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters for Magnetic Resonance Imaging and Photodynamic Therapy. Adv Funct Mater 28:
Dimofte, Andreea; Finlay, Jarod; Ong, Yi Hong et al. (2018) A quality assurance program for clinical PDT. Proc SPIE Int Soc Opt Eng 10476:
Ahn, Peter H; Finlay, Jarod C; Gallagher-Colombo, Shannon M et al. (2018) Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy. Photodiagnosis Photodyn Ther 21:28-35

Showing the most recent 10 out of 127 publications